JP2005341961A - Method of inducing human pulp cell differentiation and composition for dentin regeneration - Google Patents

Method of inducing human pulp cell differentiation and composition for dentin regeneration Download PDF

Info

Publication number
JP2005341961A
JP2005341961A JP2005045417A JP2005045417A JP2005341961A JP 2005341961 A JP2005341961 A JP 2005341961A JP 2005045417 A JP2005045417 A JP 2005045417A JP 2005045417 A JP2005045417 A JP 2005045417A JP 2005341961 A JP2005341961 A JP 2005341961A
Authority
JP
Japan
Prior art keywords
cells
dentin
dental pulp
cell
human dental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005045417A
Other languages
Japanese (ja)
Inventor
Akiko Tonomura
明子 外村
Yoshinori Ando
由典 安藤
Hideaki Kagami
秀明 各務
Minoru Ueda
実 上田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagoya University NUC
Hitachi Healthcare Manufacturing Ltd
Original Assignee
Nagoya University NUC
Hitachi Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagoya University NUC, Hitachi Medical Corp filed Critical Nagoya University NUC
Priority to JP2005045417A priority Critical patent/JP2005341961A/en
Priority to PCT/JP2005/008734 priority patent/WO2005108558A1/en
Publication of JP2005341961A publication Critical patent/JP2005341961A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/42Organic phosphate, e.g. beta glycerophosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method of inducing the differentiation of a human pulp cell to an odontoblastic cell by which a dental disease patient such as the one suffering from tooth decay can be treated; and to provide a method of regenerating the dentin. <P>SOLUTION: The method of producing the odontoblastic cell the differentiation into which has been induced involves culturing at least one of the isolated human pulp cell and the cell capable of differentiating into the human human pulp cell in the presence of 1,25-(dihydroxy)vitamin D<SB>3</SB>, dexamethasone and β-glycerophosphate. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、ヒト歯髄細胞から象牙芽細胞への分化誘導方法、象牙質の再生方法、及び象牙質再生用組成物に関する。より詳細には、本発明は、ヒト歯髄細胞を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することにより象牙芽細胞に分化させ、該細胞を担体等と一緒に培養および/または移植することにより象牙質を再生する方法に関する。本発明は上記培養により得られる象牙質再生用組成物に関する。本発明はさらに、上記方法により再生された象牙質に関する。本発明はさらに、上記方法により分化誘導された象牙芽細胞もしくは再生された象牙質を用いて歯科患者を治療する方法に関する。 The present invention relates to a method for inducing differentiation from human dental pulp cells to odontoblasts, a method for regenerating dentin, and a composition for regenerating dentin. More specifically, the present invention differentiates human dental pulp cells into odontoblasts by culturing them in the presence of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate, The present invention relates to a method for regenerating dentin by culturing and / or transplanting together. The present invention relates to a dentin regeneration composition obtained by the above culture. The present invention further relates to dentin regenerated by the above method. The present invention further relates to a method for treating a dental patient using the odontoblasts induced to differentiate by the above method or the regenerated dentin.

現代社会は高齢化社会であり、数年後には日本国民人口の約20%が65歳以上の高齢者になることが予想されている。これら高齢者の大多数は、一部又は全部の歯牙を喪失しており、多くの人は可綴式義歯(いわゆる入れ歯)を使用している。従来の義歯は、着脱が必要で装着感もよくないなどの実際的問題のみならず、心理的にも老化の象徴といった印象があり、できれば義歯を使用したくないというのが患者の一般的認識である。さらに、全ての歯牙を喪失した場合に、総義歯を装着すると、その咀嚼能力は通常の天然歯牙の約5分の1となることが知られている。さらに、脳に対する咀嚼刺激は痴呆防止の効果があり、咀嚼力の低下は痴呆の促進になることが明らかになってきている。   The modern society is an aging society, and it is expected that about 20% of the Japanese population will be 65 years old or older in a few years. The majority of these elderly people have lost some or all of their teeth, and many have used dentures (so-called dentures). Patients have the general perception that conventional dentures have not only practical problems such as attachment and detachment, but also a feeling of wearing, but also a psychological symbol of aging. It is. Furthermore, it is known that when all teeth are lost, if a complete denture is attached, the masticatory ability is about one-fifth that of a normal natural tooth. Furthermore, it has become clear that masticatory stimulation to the brain has an effect of preventing dementia, and that a decrease in masticatory power promotes dementia.

歯牙喪失の理由としてう蝕や歯周疾患が挙げられる。重度のう蝕により歯髄炎や歯髄壊死を起こした歯牙を温存するための治療としては根管治療が広く行なわれている。これはう蝕により感染した歯髄組織を除去し、人工的な薬剤で充填させる治療法であるが、根管が複雑な形状をしているために根管内を完全に密閉することができず、根管及び象牙細管内の細菌を完全に除去できていない場合、二次感染を起こし再度治療をしなければならなく、根管治療を行った歯牙の寿命は短いと言われている。歯牙を長期間維持するためには歯髄を可及的に温存し、根管治療の成功率を上げる必要がある。これらの問題を解決するためにも天然の象牙質を再生させれば完全に密閉することができるようになり、髄腔の穿孔やう蝕の治療による露髄部を閉鎖させることや、根管治療での充填材としても利用することが可能となる。   Caries and periodontal diseases are cited as reasons for tooth loss. Root canal treatment is widely used as a treatment for preserving teeth that have pulpitis or pulpal necrosis due to severe caries. This is a treatment that removes dental pulp tissue infected by caries and fills it with an artificial drug. However, the root canal cannot be completely sealed because it has a complex shape. If the bacteria in the root canal and dentinal tubules have not been completely removed, secondary infection must be performed and treatment must be performed again, and it is said that the life of a tooth subjected to root canal treatment is short. In order to maintain the tooth for a long period of time, it is necessary to preserve the pulp as much as possible and increase the success rate of root canal treatment. In order to solve these problems, it is possible to completely seal the natural dentin by regenerating natural dentin, closing the exposed medulla by medullary cavity perforation and caries treatment, and root canal treatment. It can also be used as a filler.

天然の象牙質を再生させて治療に使用する方法が提案され、検討が行なわれている。例えば、非特許文献1には、培養ヒト歯髄細胞をハイドロキシアパタイト(以下、HApと略す)とリン酸三カルシウム(以下、β−TCPと略す)の複合体の粉体に播種した試料をヌードマウス皮下へ移植して6週間後に摘出することが開示されている。そして、摘出後のヘマトキシリン/エオシン染色像から硬組織の形成が確認され、さらにこの試料から抽出したRNAを、RT−PCRを用いて評価したところ、象牙芽細胞の分化マーカーのmRNAが発現していること、すなわち、得られた硬組織が象牙質様組織であったことが開示されている。ただし、形成された硬組織の量は非常に少なく、臨床応用にはより多量の象牙質再生が求められる。   A method for regenerating natural dentin and using it for treatment has been proposed and studied. For example, Non-Patent Document 1 describes a sample of cultured human dental pulp cells seeded on a powder of a complex of hydroxyapatite (hereinafter abbreviated as HAp) and tricalcium phosphate (hereinafter abbreviated as β-TCP). It has been disclosed to be removed 6 weeks after transplantation subcutaneously. Then, the formation of hard tissue was confirmed from the hematoxylin / eosin stained image after extraction, and when RNA extracted from this sample was evaluated using RT-PCR, mRNA of the odontoblast differentiation marker was expressed. That is, it is disclosed that the obtained hard tissue was a dentin-like tissue. However, the amount of hard tissue formed is very small, and a larger amount of dentine regeneration is required for clinical application.

さらに非特許文献2には、ヒト歯髄細胞に1,25−(ジヒドロキシ)ビタミンD3とTGF−βを添加することにより、硬組織形成の指標であるアルカリホスファターゼ活性が上昇することが示されている。しかしながら、非特許文献2におけるアルカリホスファターゼ活性は不十分なものであり、また、TGF−βなどのペプチド性因子は高価で供給性に問題がある上、速やかに失活するか、もしくは至適濃度を維持することが困難であり、実用上満足できる方法ではない。 Furthermore, Non-Patent Document 2 shows that the addition of 1,25- (dihydroxy) vitamin D 3 and TGF-β to human dental pulp cells increases alkaline phosphatase activity, which is an indicator of hard tissue formation. Yes. However, the activity of alkaline phosphatase in Non-Patent Document 2 is insufficient, and peptide factors such as TGF-β are expensive and have a problem in supply, and are rapidly deactivated or have an optimum concentration. Is not a satisfactory method in practical use.

S.Gronthosら、Proc.Natl.Acad.Sci.USA,2000, 97(25):13625-13630S. Gronthos et al., Proc. Natl. Acad. Sci. USA, 2000, 97 (25): 13625-13630 P.Pavasantら、Archives of Oral Biology,2003,48,717-722P. Pavasant et al., Archives of Oral Biology, 2003, 48, 717-722

本発明は、上記した従来技術の問題点を解消することを解決すべき課題とした。即ち、本発明は、より効率的にヒト歯髄細胞から象牙質を形成する象牙芽細胞に分化させる方法を提供することを解決すべき課題とした。また、本発明は、う蝕などの歯科疾患への臨床応用に可能なほど多量な象牙質を再生する方法を提供することを解決すべき課題とした。さらに本発明は、分化誘導された象牙芽細胞又は再生した象牙質を用いてう蝕などの歯科疾患を治療する方法を提供することを解決すべき課題とした。   An object of the present invention is to solve the above-described problems of the prior art. That is, an object of the present invention is to provide a method for more efficiently differentiating human dental pulp cells into odontoblasts that form dentin. Moreover, this invention made it the problem which should be solved to provide the method of reproducing | regenerating as much dentin as possible for clinical application to dental diseases, such as a caries. Furthermore, another object of the present invention is to provide a method for treating dental diseases such as caries using differentiated odontoblasts or regenerated dentin.

本発明者らは、上記課題を解決するために鋭意検討した結果、ヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することにより、象牙質を形成する象牙芽細胞への分化を効率良く行うことができることを実証した。本発明はこれらの知見に基づいて完成したものである。 As a result of intensive studies to solve the above problems, the present inventors have determined that human dental pulp cells or cells that can differentiate into human dental pulp cells are present in the presence of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate. It was proved that the cells can be efficiently differentiated into odontoblasts that form dentin by culturing the cells. The present invention has been completed based on these findings.

即ち、本発明によれば、分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することを含む、分化誘導された象牙芽細胞の製造方法が提供される。 That is, according to the present invention, at least one of the isolated human dental pulp cells or cells that can differentiate into human dental pulp cells is cultured in the presence of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate. And a method for producing differentiation-induced odontoblasts.

好ましくは、細胞を担体上で培養する。
好ましくは、1,25(ジヒドロキシ)ビタミンD3の培地中の濃度は1×10-8〜1×10-5mol/lであり、デキサメタゾンの培地中の濃度は1×10-9〜1×10-6mol/lであり、β−グリセロホスフェートの培地中の濃度は1〜30mmol/lである。
Preferably, the cells are cultured on a carrier.
Preferably, the concentration of 1,25 (dihydroxy) vitamin D 3 in the medium is 1 × 10 −8 to 1 × 10 −5 mol / l and the concentration of dexamethasone in the medium is 1 × 10 −9 to 1 ×. 10 −6 mol / l, and the concentration of β-glycerophosphate in the medium is 1 to 30 mmol / l.

好ましくは、本発明による分化誘導された象牙芽細胞の製造方法は、(i)分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を培養する工程、(ii)当該細胞を担体に播種して培養する工程、及び(iii)当該細胞を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートを含む培地中で培養する工程、を含む。
好ましくは、担体がセラミック系担体である。
Preferably, the method for producing differentiation-induced odontoblasts according to the present invention comprises (i) a step of culturing at least one of isolated human dental pulp cells or cells that can differentiate into human dental pulp cells, (ii) the cells And (iii) culturing the cells in a medium containing 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate.
Preferably, the carrier is a ceramic carrier.

本発明の別の側面によれば、上記方法により得られる、分化誘導された象牙芽細胞が提供される。
本発明のさらに別の側面によれば、上記した分化誘導された象牙芽細胞を含む、象牙質再生用細胞組成物が提供される。
本発明のさらに別の側面によれば、上記方法により得られる分化誘導された象牙芽細胞を培養することを含む、象牙質の再生方法が提供される。
本発明のさらに別の側面によれば、上記方法により再生された象牙質が提供される。
According to another aspect of the present invention, a differentiation-induced odontoblast obtained by the above method is provided.
According to still another aspect of the present invention, there is provided a cell composition for dentin regeneration comprising the above-described differentiation-induced odontoblast.
According to still another aspect of the present invention, there is provided a method for regenerating dentin, comprising culturing differentiation-induced odontoblasts obtained by the above method.
According to still another aspect of the present invention, dentin regenerated by the above method is provided.

本発明のさらに別の側面によれば、上記方法により得られる分化誘導された象牙芽細胞、又は上記方法により再生された象牙質を患者に移植することを含む、歯科患者の治療方法が提供される。   According to still another aspect of the present invention, there is provided a method for treating a dental patient, comprising transplanting a differentiation-induced odontoblast obtained by the above method or a dentin regenerated by the above method to a patient. The

本発明の方法を利用して、培地上で象牙質を形成してから、あるいは象牙質を形成するように分化誘導された象牙芽細胞を必要に応じ担体等と共に歯科患者に移植することにより、欠損部若しくは根管を充填できるよう象牙質を再生させることができる。この結果、歯牙を維持することが可能となり二次感染の確率の低い極めて有効な治療となる。また、自らの歯牙を長期間維持できることから、患者のQuality of Life(QOL)の向上に大きく貢献する。   By using the method of the present invention, after forming dentin on the medium, or transplanting odontoblasts induced to differentiate so as to form dentin, together with a carrier or the like as necessary, The dentin can be regenerated to fill the defect or root canal. As a result, it is possible to maintain the tooth, which is a very effective treatment with a low probability of secondary infection. In addition, since it can maintain its own teeth for a long time, it greatly contributes to improving the quality of life (QOL) of patients.

以下、本発明の実施の形態について詳細に説明する。
本発明による分化誘導された象牙芽細胞の製造方法は、ヒト歯髄細胞またはヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することを特徴とする。
Hereinafter, embodiments of the present invention will be described in detail.
According to the method of producing differentiation induced odontoblast according to the present invention, at least one of human dental pulp cells or cells that can differentiate into human dental pulp cells is composed of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate. It is characterized by culturing in the presence.

本発明においてヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞は、1種類の細胞から成る単一の細胞として培養してもよいし、2種類以上の細胞からなる細胞混合物として培養してもよい。   In the present invention, human dental pulp cells or cells that can differentiate into human dental pulp cells may be cultured as a single cell composed of one type of cell, or may be cultured as a cell mixture composed of two or more types of cells. .

ヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞は、ヒトの抜去歯等から採取することができる。ヒト歯髄細胞は、例えばAbout I.,他 Experimental cell research,258,33-41,2000に記載の方法に従って採取することができる。また、ヒト歯髄細胞に分化可能な細胞は、例えば以下の方法で採取することができる。埋伏歯を無菌的に取り出し、Phosphate Buffered Saline(以下PBSと略す)溶液などの適当な保存液で保存する。歯牙の中の石灰化した部分を取り除き、メスにて組織を小片にして、PBS溶液などを用いて組織を洗浄する。次いで、コラゲナーゼやディスパーゼを用いて組織を酵素処理することが好ましい。酵素処理後、ピペッティング操作と遠心操作により細胞を回収することができる。   Human dental pulp cells or cells that can differentiate into human dental pulp cells can be collected from human extracted teeth or the like. Human dental pulp cells can be collected according to the method described in, for example, About I., Other Experimental cell research, 258, 33-41, 2000. Moreover, the cell which can be differentiated into a human dental pulp cell can be extract | collected, for example with the following method. Aseptically remove the impacted teeth and store them in a suitable storage solution such as a Phosphate Buffered Saline (hereinafter abbreviated as PBS) solution. Remove the calcified portion of the teeth, cut the tissue into small pieces with a scalpel, and wash the tissue with a PBS solution or the like. Subsequently, it is preferable to enzyme-treat the tissue using collagenase or dispase. After the enzyme treatment, the cells can be collected by pipetting and centrifugation.

細胞の培養は、動物細胞の培養に用いる通常の血清入り培地や無血清培地を用いて、通常の動物細胞の培養条件(例えば、室温から37℃の温度;5%CO2インキュベーター内など)の下で行なうことができる。また、培地には、アスコルビン酸などの添加剤を加えることも可能である。培養の形態は特に限定されないが、例えば、静置培養で行なうことができる。 Cell culture can be performed using normal serum-containing medium or serum-free medium used for animal cell culture under normal animal cell culture conditions (eg, room temperature to 37 ° C; 5% CO 2 incubator, etc.) Can be done below. Moreover, it is also possible to add additives, such as ascorbic acid, to a culture medium. Although the form of culture is not particularly limited, for example, it can be performed by static culture.

1,25(ジヒドロキシ)ビタミンD3の添加量は、培地中に1×10-8〜1×10-5mol/l、より好ましくは1×10-7〜1×10-6mol/lである。 The addition amount of 1,25 (dihydroxy) vitamin D 3 is 1 × 10 −8 to 1 × 10 −5 mol / l, more preferably 1 × 10 −7 to 1 × 10 −6 mol / l in the medium. is there.

また、デキサメタゾンの添加量は、培地中に1×10-9〜1×10-6mol/l、より好ましくは1×10-8〜1×10-7mol/lである。 Moreover, the addition amount of dexamethasone is 1 × 10 −9 to 1 × 10 −6 mol / l, more preferably 1 × 10 −8 to 1 × 10 −7 mol / l in the medium.

更に、β−グリセロホスフェートの添加量は、培地中に1〜30mmol/l、より好ましくは2〜10mmol/lである。   Furthermore, the addition amount of (beta) -glycerophosphate is 1-30 mmol / l in a culture medium, More preferably, it is 2-10 mmol / l.

本発明において、細胞の培養は担体上で行ってもよいし、担体無しで培養してもよい。担体としては、象牙質の形成に必要とされる時間を耐久することができ、かつその後、速やかに吸収されるものが好ましい。さらに、細胞と高い親和性を有する材料からなる担体を使用することが好ましい。   In the present invention, cells may be cultured on a carrier or may be cultured without a carrier. As the carrier, a carrier that can endure the time required for the formation of dentin and is rapidly absorbed thereafter is preferable. Furthermore, it is preferable to use a carrier made of a material having high affinity for cells.

担体の素材は、上記特性を満たすものであれば特に限定されないが、例えば、セラミック系の材料(例えば、ハイドロキシアパタイト(HAp)、リン酸三カルシウム(β−TCP)、リン酸四カルシウム)、ポリグリコール酸(PGA)、ポリ(DL−ラクチド−コ−グリコシド)(PLGA)、ポリ乳酸(PLLA)、ポリカプロラクトンなどの合成高分子材料、またはコラーゲン、ゼラチン、フィブリンなどの蛋白質材料、あるいはヒアルロン酸及びその塩、アルギン酸及びその塩、象牙、サンゴなどの天然由来材料を使用することもできる。   The material of the carrier is not particularly limited as long as it satisfies the above characteristics. For example, ceramic materials (for example, hydroxyapatite (HAp), tricalcium phosphate (β-TCP), tetracalcium phosphate), poly Synthetic polymer materials such as glycolic acid (PGA), poly (DL-lactide-co-glycoside) (PLGA), polylactic acid (PLLA), polycaprolactone, or protein materials such as collagen, gelatin, fibrin, or hyaluronic acid and Naturally derived materials such as salts thereof, alginic acid and salts thereof, ivory and coral can also be used.

PGA、PLLA、PLGAまたはポリカプロラクトンなどの合成材料を使用する場合には、細胞の接着及び増殖性を高めるために、表面にコラーゲン溶液又はフィブロネクチン溶液などをコートして使用することもできる。   In the case of using a synthetic material such as PGA, PLLA, PLGA, or polycaprolactone, the surface may be coated with a collagen solution or a fibronectin solution in order to enhance cell adhesion and proliferation.

上記の担体の形態としては、メッシュ形態、スポンジ形態、ゲル形態、不織布形態、粒状形態などが可能である。   As the form of the carrier, a mesh form, a sponge form, a gel form, a non-woven form, a granular form, and the like are possible.

担体は細胞を移植しやすい形状に加工したものが好ましく、板状、球状の多孔体あるいは中空で一端が開放されており、周囲から血管が進入しやすくなっているものが好ましい。   The carrier is preferably processed into a shape in which cells can be easily transplanted, and is preferably a plate-like or spherical porous body or hollow, with one end being opened and a blood vessel easily entering from the periphery.

担体は、目的に適合した形態のものを作製することが好ましい。このためには、目的とする形態をレジンで作製した後に印象材を用いて型を取得する。その後、レジンの型を取り出し、担体を構成する合成材料を流し込むことによって目的の形態を再現することができる。   The carrier is preferably prepared in a form suitable for the purpose. For this purpose, a mold is obtained using an impression material after a desired form is made of a resin. Thereafter, the desired form can be reproduced by taking out the resin mold and pouring the synthetic material constituting the carrier.

本発明の一実施態様によれば、本発明の方法は、以下の3工程を含むことができる。
(i)分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を培養する工程(一次培養);
(ii)当該細胞を担体に播種して培養する工程(二次培養);及び
(iii)当該細胞を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートを含む培地中で培養する工程(分化誘導):
According to one embodiment of the present invention, the method of the present invention can include the following three steps.
(I) a step of culturing at least one of the separated human dental pulp cells or cells that can differentiate into human dental pulp cells (primary culture);
(Ii) a step of seeding and culturing the cells on a carrier (secondary culture); and (iii) culturing the cells in a medium containing 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate. Process (differentiation induction):

上記の工程(i)は、以後の工程において象牙質を再生するのに必要な数の細胞を得るために行う培養である。工程(i)における細胞の培養は、動物細胞の培養に用いる通常の血清入り培地や無血清培地を用いて、通常の動物細胞の培養条件(例えば、室温から37℃の温度;5%CO2インキュベーター内など)の下で行なうことができる。また、培地には、アスコルビン酸などの添加剤を加えることも可能である。培養の形態は特に限定されないが、例えば、静置培養で行なうことができる。また、工程(i)で得られた細胞は、凍結保存しておくことも可能であり、必要時に解凍して増殖させたものを、上記工程(ii)以降の操作に使用することもできる。この手法によれば、象牙質再生を行う度に細胞を採取する必要がなくなり、患者の負担を軽減することができる。 The above step (i) is a culture performed in order to obtain a number of cells necessary for regenerating dentin in the subsequent steps. The cell culture in the step (i) is performed using a normal serum-containing medium or a serum-free medium used for animal cell culture under normal animal cell culture conditions (for example, a temperature from room temperature to 37 ° C .; 5% CO 2 Under the incubator). Moreover, it is also possible to add additives, such as ascorbic acid, to a culture medium. Although the form of culture is not particularly limited, for example, it can be performed by static culture. In addition, the cells obtained in step (i) can be stored frozen, and those that have been thawed and expanded as necessary can be used in the operations after step (ii). According to this method, it is not necessary to collect cells each time dentin regeneration is performed, and the burden on the patient can be reduced.

上記の工程(ii)は、担体上で細胞を増殖させる工程である。担体に播種した細胞は、担体に接着して、増殖する。工程(ii)における細胞の培養も、動物細胞の培養に用いる通常の血清入り培地や無血清培地を用いて、通常の動物細胞の培養条件(例えば、室温から37℃の温度;5%CO2インキュベーター内など)の下で行なうことができる。培養期間としては、好ましくは1〜30日、さらに好ましくは5〜25日である。 The above step (ii) is a step of growing cells on a carrier. The cells seeded on the carrier grow by adhering to the carrier. The cell culture in the step (ii) is also performed by using a normal serum-containing medium or serum-free medium used for animal cell culture under normal animal cell culture conditions (for example, a temperature from room temperature to 37 ° C .; 5% CO 2 Under the incubator). The culture period is preferably 1 to 30 days, more preferably 5 to 25 days.

上記の工程(iii)は、象牙芽細胞への分化誘導を促進する工程である。1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの使用量は本明細書中上記した通りである。 The above step (iii) is a step of promoting differentiation induction into odontoblasts. The amounts used of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate are as described above in the present specification.

本発明の方法では、ヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞を担体に播種して、または必要に応じて播種後培養し、該培養細胞を担体と一緒に直接患者に移植しても良い。あるいはさらに好ましくは、分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞を培養して増殖させた後に担体に播種して、または必要に応じて播種後培養し、次いで該培養細胞を担体と一緒に移植し、体内で象牙質を再生させることができる。   In the method of the present invention, human dental pulp cells or cells that can differentiate into human dental pulp cells are seeded on a carrier, or if necessary, cultured after seeding, and the cultured cells can be directly transplanted to a patient together with the carrier. good. Alternatively, more preferably, isolated human dental pulp cells or cells that can differentiate into human dental pulp cells are cultured and expanded and then seeded on a carrier, or if necessary, cultured after seeding, and then the cultured cells are used as a carrier. Can be transplanted together to regenerate dentin in the body.

あるいはまた、分離したヒト歯髄細胞若しくはヒト歯髄細胞に分化可能な細胞を培養して増殖させた後に担体に播種して、または必要に応じて播種後培養し、次いで該培養細胞を担体と一緒に移植動物に移植し、該移植動物の体内で象牙質を再生させることができる。 移植動物の種類は特に限定されないが、好ましくは哺乳動物であり、例えば、マウス(ヌードマウスなど)、ラット(ヌードラットなど)などのげっ歯類動物を使用することができる。移植の部位は特に限定されず、例えば、背部皮下などが挙げられる。   Alternatively, isolated human dental pulp cells or cells that can be differentiated into human dental pulp cells are cultured and expanded and then seeded on a carrier or cultured after seeding if necessary, and then the cultured cells are combined with the carrier. It can be transplanted into a transplanted animal, and the dentin can be regenerated in the body of the transplanted animal. Although the kind of transplant animal is not specifically limited, Preferably it is a mammal, For example, rodent animals, such as a mouse | mouth (nude mouse etc.) and a rat (nude rat etc.), can be used. The site of transplantation is not particularly limited, and examples include subcutaneous dorsal part.

上記した本発明の方法により分化誘導された象牙芽細胞及び本発明の方法により再生した象牙質は、う蝕などの歯科疾患を有する患者に移植することによって、該歯科患者を治療することができる。即ち、象牙質を用いる歯科疾患の治療方法、例えば、髄腔の穿孔や露髄部の治療、根管治療などへの適用も本発明の範囲内のものである。歯科患者に移植された後も象牙質の成長を継続させることにより、象牙質を形成させることができる。
以下の実施例により本発明をさらに具体的に説明するが、本発明は実施例によって限定されるものではない。
The odontoblasts induced to differentiate by the above-described method of the present invention and the dentin regenerated by the method of the present invention can be treated by transplanting them into a patient having a dental disease such as caries. . That is, application to a method for treating a dental disease using dentin, for example, perforation of the medullary cavity, treatment of the exposed pulp, root canal treatment, and the like is also within the scope of the present invention. The dentin can be formed by continuing the growth of the dentin even after being transplanted to the dental patient.
The following examples further illustrate the present invention, but the present invention is not limited to the examples.

比較例1:培養ヒト歯髄細胞の細胞数とALPase活性の測定(添加因子を加えない条件)
(1)採取保存
医師によるインフォームドコンセントの得られた患者(29歳女性)の智歯を使用した。治療のため抜歯した智歯をタービンで削り、歯髄を露出させ、無菌的に歯髄組織を採取し、10%抗生剤入りPBS溶液にて保存した。
Comparative Example 1: Measurement of cell number and ALPase activity of cultured human dental pulp cells (conditions without added factor)
(1) Collection and preservation The wisdom of a patient (29-year-old female) who obtained informed consent by a doctor was used. The extracted wisdom tooth was scraped with a turbine to expose the pulp, and the pulp tissue was aseptically collected and stored in a PBS solution containing 10% antibiotic.

メスにて歯髄組織を約2mmの小片にし、PBS溶液にて5回洗浄した。   The pulp tissue was cut into small pieces of about 2 mm with a scalpel and washed 5 times with PBS solution.

(2)細胞回収
2mg/mlコラゲナーゼをDMEM培地に溶解した酵素溶液を用いて、洗浄した組織を50分間酵素処理した。得られた組織を25ml用のピペットを用いて10分間ピペッティングした。25mlの上澄み液を遠心分離して細胞を回収した。得られた細胞をDMEM培地とNutrient Mixture F-12を1:1で混合した(以下DMEM/F12と略す)培地に15%血清を入れた培地にて5回洗浄した後、70μmセルストレイナーでろ過し、遠心分離することによって細胞を回収した。
(2) Cell recovery
The washed tissue was enzymatically treated for 50 minutes using an enzyme solution in which 2 mg / ml collagenase was dissolved in DMEM medium. The resulting tissue was pipetted for 10 minutes using a 25 ml pipette. The 25 ml supernatant was centrifuged to recover the cells. The obtained cells were washed five times with a medium in which DMEM medium and Nutrient Mixture F-12 were mixed 1: 1 (hereinafter abbreviated as DMEM / F12) containing 15% serum, and then filtered through a 70 μm cell strainer. The cells were collected by centrifugation.

(3)静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした後、37℃、5%CO2条件下で静置培養を行なった。
(3) Static culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured under conditions of 37 ° C. and 5% CO 2 and subcultured twice. The cells were detached from the cell culture flask with trypsin-EDTA, seeded at 1 × 10 4 cells / well in a 12-well plate, and then statically cultured under conditions of 37 ° C. and 5% CO 2 .

(4)測定
ALPase活性の測定にはp-Nitrophenyl phosphate tablets sets(SIGMA社製)を使用した。細胞播種後、7日間および10日間経過したプレートの培養上清を吸引除去し、PBS溶液で洗浄した後、パラニトロフェニルリン酸(以下PNPPと略す)溶液を各ウェルに800μlずつ添加して、37℃、5% CO2条件下で6分間反応させた。0.2NのNaOH溶液を等量加えて反応を停止させ、96穴プレートに200μl添加し、マイクロプレートリーダー(TECAN社製GENios)を用いて415nmの吸光度を測定した。
(4) Measurement
For measurement of ALPase activity, p-Nitrophenyl phosphate tablets sets (manufactured by SIGMA) were used. After cell seeding, the culture supernatant of the plate after 7 days and 10 days has been removed by suction, washed with PBS solution, and then added 800 μl of paranitrophenyl phosphate (hereinafter abbreviated as PNPP) solution to each well. The reaction was carried out for 6 minutes at 37 ° C. and 5% CO 2 . An equal amount of 0.2N NaOH solution was added to stop the reaction, 200 μl was added to a 96-well plate, and the absorbance at 415 nm was measured using a microplate reader (GENios manufactured by TECAN).

細胞数の測定にはCell Counting Kit-8(同仁化学研究所社製)を用いた。細胞播種後、7日間および10日間経過したプレートの培養上清を吸引除去し、DMEM/F12培地を各ウェルに1mlずつ加え、Cell Counting Kit-8溶液を各ウェルに100μlずつ添加して、37℃、5%CO2条件下で60分間呈色反応を行なった。反応後の試薬溶液を蒸留水で4倍希釈して、96穴プレートに200μl添加し、マイクロプレートリーダー(TECAN社製GENios)を用いて450nmの吸光度を測定した。 Cell Counting Kit-8 (manufactured by Dojindo Laboratories) was used for the measurement of the number of cells. After cell seeding, the culture supernatant of the plate after 7 days and 10 days is removed by aspiration, 1 ml of DMEM / F12 medium is added to each well, and 100 μl of Cell Counting Kit-8 solution is added to each well. The color reaction was carried out for 60 minutes under the conditions of 5 ° C. and 5% CO 2 . The reagent solution after the reaction was diluted 4-fold with distilled water, 200 μl was added to a 96-well plate, and absorbance at 450 nm was measured using a microplate reader (GENios manufactured by TECAN).

(5)結果
測定した結果を、図1(ind(-))に示す。
(5) Results The measured results are shown in Fig. 1 (ind (-)).

比較例2:TGF-β1と1,25(ジヒドロキシ)ビタミンD3を添加して培養したヒト歯髄細胞の細胞数とALPase活性の測定(非特許文献2記載の条件)
なお、以下の比較例2においては、(1)採取保存、(2)細胞回収、(4)測定は、比較例1と同じ条件下で行っており、条件の異なる静置培養と結果についてのみ詳述する。
Comparative Example 2: Measurement of cell number and ALPase activity of human dental pulp cells cultured with addition of TGF-β1 and 1,25 (dihydroxy) vitamin D 3 (conditions described in Non-Patent Document 2)
In Comparative Example 2 below, (1) collection and storage, (2) cell recovery, and (4) measurement were performed under the same conditions as in Comparative Example 1, and only for static culture and results under different conditions. Detailed description.

静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした。培養には1ng/mlTGF-β1、10-8mol/l1,25(ジヒドロキシ)ビタミンD3を添加した15%血清入りDMEM/F12培地を用いて37℃、5%CO2条件下で静置培養を行なった。
Stationary culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C under 5% CO 2 , and cells passaged twice were trypsinized. After peeling from the cell culture flask with -EDTA, 1 × 10 4 cells / well were seeded in a 12-well plate. Cultivation is carried out by using a DMEM / F12 medium containing 15% serum supplemented with 1 ng / ml TGF-β1, 10 -8 mol / l 1,25 (dihydroxy) vitamin D 3 at 37 ° C and 5% CO 2. Was done.

結果
測定した結果を、図1(TGF+VD)に示す。
Results The measurement results are shown in FIG. 1 (TGF + VD).

比較例3:培養ヒト歯髄細胞の細胞数とALPase活性の測定(添加因子を加えない条件)
(6)採取保存
医師によるインフォームドコンセントの得られた患者(24歳女性)の智歯を使用した。治療のため抜歯した智歯をタービンで削り、歯髄を露出させ、無菌的に歯髄組織を採取し、10%抗生剤入りPBS溶液にて保存した。
Comparative Example 3: Measurement of the number of cultured human dental pulp cells and ALPase activity (conditions without added factor)
(6) Collection and preservation The wisdom of a patient (24-year-old woman) who obtained informed consent by a doctor was used. The extracted wisdom tooth was scraped with a turbine to expose the pulp, and the pulp tissue was aseptically collected and stored in a PBS solution containing 10% antibiotic.

メスにて歯髄組織を約2mmの小片にし、PBS溶液にて5回洗浄した。   The pulp tissue was cut into small pieces of about 2 mm with a scalpel and washed 5 times with PBS solution.

(7)細胞回収
2mg/mlコラゲナーゼをDMEM培地に溶解した酵素溶液を用いて、洗浄した組織を50分間酵素処理した。得られた組織を25ml用のピペットを用いて10分間ピペッティングした。25mlの上澄み液を遠心分離して細胞を回収した。得られた細胞をDMEM培地とNutrient Mixture F-12を1:1で混合した(以下DMEM/F12と略す)培地に15%血清を入れた培地にて5回洗浄した後、70μmセルストレイナーでろ過し、遠心分離することによって細胞を回収した。
(7) Cell recovery
The washed tissue was enzymatically treated for 50 minutes using an enzyme solution in which 2 mg / ml collagenase was dissolved in DMEM medium. The resulting tissue was pipetted for 10 minutes using a 25 ml pipette. The 25 ml supernatant was centrifuged to recover the cells. The obtained cells were washed five times with a medium in which DMEM medium and Nutrient Mixture F-12 were mixed 1: 1 (hereinafter abbreviated as DMEM / F12) containing 15% serum, and then filtered through a 70 μm cell strainer. The cells were collected by centrifugation.

(8)静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、4 回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした後、37℃、5%CO2条件下で静置培養を行なった。
(8) Static culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured under conditions of 37 ° C. and 5% CO 2 for 4 passages. The cells were detached from the cell culture flask with trypsin-EDTA, seeded at 1 × 10 4 cells / well in a 12-well plate, and then statically cultured under conditions of 37 ° C. and 5% CO 2 .

(9)測定
ALPase活性の測定にはp-Nitrophenyl phosphate tablets sets(SIGMA社製)を使用した。細胞播種後、7日間および10日間経過したプレートの培養上清を吸引除去し、PBS溶液で洗浄した後、パラニトロフェニルリン酸(以下PNPPと略す)溶液を各ウェルに800μlずつ添加して、37℃、5%CO2条件下で6分間反応させた。0.2NのNaOH溶液を等量加えて反応を停止させ、96穴プレートに200μl添加し、マイクロプレートリーダー(TECAN社製GENios)を用いて415nmの吸光度を測定した。
(9) Measurement
For measurement of ALPase activity, p-Nitrophenyl phosphate tablets sets (manufactured by SIGMA) were used. After cell seeding, the culture supernatant of the plate after 7 days and 10 days has been removed by suction, washed with PBS solution, and then added 800 μl of paranitrophenyl phosphate (hereinafter abbreviated as PNPP) solution to each well. The reaction was carried out for 6 minutes at 37 ° C. and 5% CO 2 . An equal amount of 0.2N NaOH solution was added to stop the reaction, 200 μl was added to a 96-well plate, and the absorbance at 415 nm was measured using a microplate reader (GENios manufactured by TECAN).

細胞数の測定にはCell Counting Kit-8(同仁化学研究所社製)を用いた。細胞播種後、7日間および10日間経過したプレートの培養上清を吸引除去し、DMEM/F12培地を各ウェルに1mlずつ加え、Cell Counting Kit-8溶液を各ウェルに100μlずつ添加して、37℃、5%CO2条件下で60分間呈色反応を行なった。反応後の試薬溶液を蒸留水で4倍希釈して、96穴プレートに200μl添加し、マイクロプレートリーダー(TECAN社製GENios)を用いて450nmの吸光度を測定した。 Cell Counting Kit-8 (manufactured by Dojindo Laboratories) was used for the measurement of the number of cells. After cell seeding, the culture supernatant of the plate after 7 days and 10 days is removed by aspiration, 1 ml of DMEM / F12 medium is added to each well, and 100 μl of Cell Counting Kit-8 solution is added to each well. The color reaction was carried out for 60 minutes under the conditions of 5 ° C. and 5% CO 2 . The reagent solution after the reaction was diluted 4-fold with distilled water, 200 μl was added to a 96-well plate, and absorbance at 450 nm was measured using a microplate reader (GENios manufactured by TECAN).

(10)結果
測定した結果を、図2(ind(-))に示す。
(10) Results The measurement results are shown in FIG. 2 (ind (−)).

比較例4:デキサメタゾンとリン酸二水素カリウムなどを添加し、培養したヒト歯髄細胞の細胞数とALPase活性の測定(非特許文献1記載の条件)なお、以下の比較例4においては、(6)採取保存、(7)細胞回収、(9)測定は、比較例3と同じ条件下で行っており、条件の異なる静置培養と結果についてのみ詳述する。 Comparative Example 4: Measurement of the number and ALPase activity of human dental pulp cells cultured with dexamethasone and potassium dihydrogen phosphate added (conditions described in Non-Patent Document 1) In the following Comparative Example 4, (6 The collection and storage, (7) cell recovery, and (9) measurement are performed under the same conditions as in Comparative Example 3, and only the static culture and the results under different conditions will be described in detail.

静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、4回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした。培養には100μmol/lアスコルビン酸、10-8 mol/lDexamethasone、2.9mmol/ l リン酸二水素カリウム、20mmol/l HEPES([2−[4−(2−ヒドロキシエチル)−1−ピペラジニル]エタンスルホン酸)を添加した15%血清入りDMEM/F12培地を用いて37℃、5%CO2条件下で静置培養を行なった。
Stationary culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and ascorbic acid at 37 ° C., 5% CO 2. After peeling from the cell culture flask with -EDTA, 1 × 10 4 cells / well were seeded in a 12-well plate. For culture, 100 μmol / l ascorbic acid, 10 −8 mol / l Dexamethasone, 2.9 mmol / l potassium dihydrogen phosphate, 20 mmol / l HEPES ([2- [4- (2-hydroxyethyl) -1-piperazinyl] ethanesulfone Using DMEM / F12 medium containing 15% serum supplemented with (acid), static culture was performed under conditions of 37 ° C. and 5% CO 2 .

結果
測定した結果を、図2(Dex+KH2PO4)に示す。
Results The measurement results are shown in FIG. 2 (Dex + KH 2 PO 4 ).

比較例5:βグリセロリン酸とデキサメタゾンを添加して培養したヒト歯髄細胞の細胞数とALPase活性の測定(1,25(ジヒドロキシ)ビタミンD3のみ添加しない条件)なお、以下の比較例5においては、(6)採取保存、(7)細胞回収、(9)測定は、比較例3と同じ条件下で行っており、条件の異なる静置培養と結果についてのみ詳述する。 Comparative Example 5: Measurement of cell number and ALPase activity of human dental pulp cells cultured with β-glycerophosphate and dexamethasone added (conditions in which only 1,25 (dihydroxy) vitamin D 3 is not added) In Comparative Example 5 below, , (6) Collection and storage, (7) Cell recovery, and (9) Measurement are performed under the same conditions as in Comparative example 3, and only the static culture and the results under different conditions will be described in detail.

静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした。培養には10mmol/lβ-Glycerophosphate、10-8mol/ l Dexamethasoneを添加した15%血清入りDMEM/F12培地を用いて37℃、5%CO2条件下で静置培養を行なった。
Stationary culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C under 5% CO 2 , and cells passaged twice were trypsinized. After peeling from the cell culture flask with -EDTA, 1 × 10 4 cells / well were seeded in a 12-well plate. For the culture, static culture was performed at 37 ° C. and 5% CO 2 using a DMEM / F12 medium containing 15% serum supplemented with 10 mmol / l β-Glycerophosphate and 10 −8 mol / l Dexamethasone.

結果
測定した結果を、図2(βGly+Dex)に示す。
Results The measurement results are shown in FIG. 2 (βGly + Dex).

比較例6:培養ヒト歯髄細胞の細胞数とALPase活性の測定(添加因子を加えない条件)
(11)採取保存
医師によるインフォームドコンセントの得られた患者(22歳女性)の智歯を使用した。治療のため抜歯した智歯をタービンで削り、歯髄を露出させ、無菌的に歯髄組織を採取し、10%抗生剤入りPBS溶液にて保存した。
Comparative Example 6: Measurement of the number of cultured human dental pulp cells and ALPase activity (conditions without addition factor)
(11) Collection and preservation The wisdom of a patient (22-year-old female) who obtained informed consent by a doctor was used. The extracted wisdom tooth was scraped with a turbine to expose the pulp, and the pulp tissue was aseptically collected and stored in a PBS solution containing 10% antibiotic.

メスにて歯髄組織を約2mmの小片にし、PBS溶液にて5回洗浄した。   The pulp tissue was cut into small pieces of about 2 mm with a scalpel and washed 5 times with PBS solution.

(12)細胞回収
2mg/mlコラゲナーゼをDMEM培地に溶解した酵素溶液を用いて、洗浄した組織を50分間酵素処理した。得られた組織を25ml用のピペットを用いて10分間ピペッティングした。25mlの上澄み液を遠心分離して細胞を回収した。得られた細胞をDMEM培地とNutrient Mixture F-12を1:1で混合した(以下DMEM/F12と略す)培地に15%血清を入れた培地にて5回洗浄した後、70μmセルストレイナーでろ過し、遠心分離することによって細胞を回収した。
(12) Cell recovery
The washed tissue was enzymatically treated for 50 minutes using an enzyme solution in which 2 mg / ml collagenase was dissolved in DMEM medium. The resulting tissue was pipetted for 10 minutes using a 25 ml pipette. The 25 ml supernatant was centrifuged to recover the cells. The obtained cells were washed five times with a medium in which DMEM medium and Nutrient Mixture F-12 were mixed 1: 1 (hereinafter abbreviated as DMEM / F12) containing 15% serum, and then filtered through a 70 μm cell strainer. The cells were collected by centrifugation.

(13)静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした後、37℃、5%CO2条件下で静置培養を行なった。
(13) Static culture The collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l at 37 ° C. under 5% CO 2 condition, and subcultured twice. The cells were detached from the cell culture flask with trypsin-EDTA, seeded at 1 × 10 4 cells / well in a 12-well plate, and then statically cultured under conditions of 37 ° C. and 5% CO 2 .

(14)測定
ALPase活性の測定にはp-Nitrophenyl phosphate tablets sets(SIGMA社製)を使用した。細胞播種後、7日間および10日間経過したプレートの培養上清を吸引除去し、PBS溶液で洗浄した後、パラニトロフェニルリン酸(以下PNPPと略す)溶液を各ウェルに800μlずつ添加して、37℃、5%CO2条件下で6分間反応させた。0.2NのNaOH溶液を等量加えて反応を停止させ、96穴プレートに200μl添加し、マイクロプレートリーダー(TECAN社製GENios)を用いて415nmの吸光度を測定した。
(14) Measurement
For measurement of ALPase activity, p-Nitrophenyl phosphate tablets sets (manufactured by SIGMA) were used. After cell seeding, the culture supernatant of the plate after 7 days and 10 days has been removed by suction, washed with PBS solution, and then added 800 μl of paranitrophenyl phosphate (hereinafter abbreviated as PNPP) solution to each well. The reaction was carried out for 6 minutes at 37 ° C. and 5% CO 2 . An equal amount of 0.2N NaOH solution was added to stop the reaction, 200 μl was added to a 96-well plate, and the absorbance at 415 nm was measured using a microplate reader (GENios manufactured by TECAN).

細胞数の測定にはCell Counting Kit-8(同仁化学研究所社製)を用いた。細胞播種後、7日間および10日間経過したプレートの培養上清を吸引除去し、DMEM/F12培地を各ウェルに1mlずつ加え、Cell Counting Kit-8溶液を各ウェルに100μlずつ添加して、37℃、5%CO2条件下で60分間呈色反応を行なった。反応後の試薬溶液を蒸留水で4倍希釈して、96穴プレートに200μl添加し、マイクロプレートリーダー(TECAN社製GENios)を用いて450nmの吸光度を測定した。 Cell Counting Kit-8 (manufactured by Dojindo Laboratories) was used for the measurement of the number of cells. After cell seeding, the culture supernatant of the plate after 7 days and 10 days is removed by aspiration, 1 ml of DMEM / F12 medium is added to each well, and 100 μl of Cell Counting Kit-8 solution is added to each well. The color reaction was carried out for 60 minutes under the conditions of 5 ° C. and 5% CO 2 . The reagent solution after the reaction was diluted 4-fold with distilled water, 200 μl was added to a 96-well plate, and absorbance at 450 nm was measured using a microplate reader (GENios manufactured by TECAN).

(15)結果
測定した結果を、図3(ind(-))に示す。
(15) Results The measured results are shown in FIG. 3 (ind (-)).

比較例7:βグリセロリン酸とデキサメタゾンを添加して培養したヒト歯髄細胞の細胞数とALPase活性の測定(1,25(ジヒドロキシ)ビタミンD3のみ添加しない条件)なお、以下の比較例7においては、(11)採取保存、(12)細胞回収、(14)測定は、比較例6と同じ条件下で行っており、条件の異なる静置培養と結果についてのみ詳述する。 Comparative Example 7: Measurement of cell number and ALPase activity of human dental pulp cells cultured with β-glycerophosphate and dexamethasone added (conditions in which only 1,25 (dihydroxy) vitamin D 3 is not added) In the following Comparative Example 7, , (11) collection and storage, (12) cell recovery, and (14) measurement are performed under the same conditions as in Comparative Example 6, and only static culture and results under different conditions will be described in detail.

静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした。培養には10mmol/lβ-Glycerophosphate、10-8mol/ l Dexamethasoneを添加した15%血清入りDMEM/F12培地を用いて37℃、5%CO2条件下で静置培養を行なった。
Stationary culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C under 5% CO 2 , and cells passaged twice were trypsinized. After peeling from the cell culture flask with -EDTA, 1 × 10 4 cells / well were seeded in a 12-well plate. For the culture, static culture was performed at 37 ° C. and 5% CO 2 using a DMEM / F12 medium containing 15% serum supplemented with 10 mmol / l β-Glycerophosphate and 10 −8 mol / l Dexamethasone.

結果
測定した結果を、図3(βGly+Dex)に示す。
Results The measurement results are shown in FIG. 3 (βGly + Dex).

実施例1:分化誘導因子を添加して培養したヒト歯髄細胞の細胞数とALPase活性の測定 なお、以下の実施例1においては、(1)採取保存、(2)細胞回収、(4)測定は、比較例1と同じ条件下で行っており、条件の異なる静置培養と結果についてのみ詳述する。 Example 1: Measurement of number and ALPase activity of human dental pulp cells cultured with addition of differentiation-inducing factor In Example 1 below, (1) collection and storage, (2) cell recovery, (4) measurement Is performed under the same conditions as in Comparative Example 1, and only the static culture and the results under different conditions will be described in detail.

静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした。培養には100μmol/lアスコルビン酸、10-6mol/l1,25(ジヒドロキシ)ビタミンD3、10mmol/lβ-Glycerophosphate、10-8mol/ l Dexamethasoneを添加した15%血清入りDMEM/F12培地を用いて37℃、5%CO2条件下で静置培養を行なった。
Stationary culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C under 5% CO 2 , and cells passaged twice were trypsinized. After peeling from the cell culture flask with -EDTA, 1 × 10 4 cells / well were seeded in a 12-well plate. DMEM / F12 medium containing 15% serum supplemented with 100 μmol / l ascorbic acid, 10 −6 mol / l 1,25 (dihydroxy) vitamin D 3 , 10 mmol / l β-Glycerophosphate, 10 −8 mol / l Dexamethasone The static culture was performed under the conditions of 37 ° C. and 5% CO 2 .

結果
測定した結果を、図1(VD+βGly+Dex)に示す。
Results The measurement results are shown in FIG. 1 (VD + βGly + Dex).

以上の比較例1(添加因子を加えない条件)、比較例2(非特許文献2記載の条件)および実施例1を比較すると、実施例1記載の条件の場合、細胞の分化が進むため細胞の増殖性は低下するが、歯髄細胞への分化及び象牙質形成能の一指標であるALPase活性は顕著に増加している(図1)。   When the above Comparative Example 1 (conditions in which no additive factor is added), Comparative Example 2 (conditions described in Non-Patent Document 2) and Example 1 are compared, in the case of the conditions described in Example 1, cell differentiation proceeds. However, the ALPase activity, which is an index of the ability to differentiate into dental pulp cells and the ability to form dentin, is significantly increased (FIG. 1).

実施例2:分化誘導因子を添加して培養したヒト歯髄細胞の細胞数とALPase活性の測定 なお、以下の実施例2においては、(11)採取保存、(12)細胞回収、(14)測定は、比較例6と同じ条件下で行っており、条件の異なる静置培養と結果についてのみ詳述する。 Example 2: Measurement of number and ALPase activity of human dental pulp cells cultured with addition of differentiation-inducing factor In Example 2 below, (11) collection and storage, (12) cell recovery, and (14) measurement Is performed under the same conditions as in Comparative Example 6, and only the static culture and the results under different conditions will be described in detail.

静置培養
回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、2回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、12ウェルプレートに1×104個/well播種をした。培養には100μmol/lアスコルビン酸、10-6mol/l1,25(ジヒドロキシ)ビタミンD3、10mmol/lβ-Glycerophosphate、10-8mol/ l Dexamethasoneを添加した15%血清入りDMEM/F12培地を用いて37℃、5%CO2条件下で静置培養を行なった。
Stationary culture Collected cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C under 5% CO 2 , and cells passaged twice were trypsinized. After peeling from the cell culture flask with -EDTA, 1 × 10 4 cells / well were seeded in a 12-well plate. DMEM / F12 medium containing 15% serum supplemented with 100 μmol / l ascorbic acid, 10 −6 mol / l 1,25 (dihydroxy) vitamin D 3 , 10 mmol / l β-Glycerophosphate, 10 −8 mol / l Dexamethasone The static culture was performed under the conditions of 37 ° C. and 5% CO 2 .

結果
測定した結果を、図3(VD+βGly+Dex)に示す。
Results The measurement results are shown in FIG. 3 (VD + βGly + Dex).

以上の比較例3(添加因子を加えない条件)、比較例4(非特許文献1記載の条件)および比較例5(1,25(ジヒドロキシ)ビタミンD3のみ添加しない条件)を比較すると、比較例5において歯髄細胞への分化及び象牙質形成能の一指標であるALPase活性が最も増加している(図2)。 Comparing the above Comparative Example 3 (conditions in which no additive factor is added), Comparative Example 4 (conditions described in Non-Patent Document 1) and Comparative Example 5 (conditions in which only 1,25 (dihydroxy) vitamin D 3 is not added) are compared. In Example 5, ALPase activity, which is an index of differentiation into dental pulp cells and dentin formation ability, is most increased (FIG. 2).

更に同様に比較例6(添加因子を加えない条件)、比較例7(1,25(ジヒドロキシ)ビタミンD3のみ添加しない条件)および実施例2を比較すると、実施例2の条件の場合、歯髄細胞への分化及び象牙質形成能の一指標であるALPase活性が顕著に増加している(図3)。すなわち、図2および図3の結果から明らかに非特許文献1記載の条件より実施例2の条件の方が効果があることが分かる。 Similarly, when Comparative Example 6 (conditions in which no additive factor is added), Comparative Example 7 (conditions in which only 1,25 (dihydroxy) vitamin D 3 is not added) and Example 2 are compared, in the case of the conditions of Example 2, the dental pulp ALPase activity, which is an index of cell differentiation and dentin formation ability, is significantly increased (FIG. 3). That is, the results of FIGS. 2 and 3 clearly show that the conditions of Example 2 are more effective than the conditions described in Non-Patent Document 1.

比較例8:象牙芽細胞への分化誘導を促進する工程を含まない移植実験
医師によるインフォームドコンセントの得られた患者(21歳男性)の智歯を使用した。治療のため抜歯した智歯をタービンで削り、歯髄を露出させ、無菌的に歯髄組織を採取し、10%抗生剤入りPBS溶液にて保存した。
Comparative Example 8: Transplantation experiment not including the step of promoting differentiation induction into odontoblasts The wisdom of a patient (21-year-old male) who obtained informed consent by a doctor was used. The extracted wisdom tooth was scraped with a turbine to expose the pulp, and the pulp tissue was aseptically collected and stored in a PBS solution containing 10% antibiotic.

メスにて歯髄組織を約2mmの小片にし、PBS溶液にて5回洗浄した。   The pulp tissue was cut into small pieces of about 2 mm with a scalpel and washed 5 times with PBS solution.

2mg/mlコラゲナーゼをDMEM培地に溶解した酵素溶液を用いて、洗浄した組織を50分間酵素処理した。得られた組織を25ml用のピペットを用いて10分間ピペッティングした。25mlの上澄み液を遠心分離して細胞を回収した。得られた細胞をDMEM/F12培地に15%血清を入れた培地にて5回洗浄した後、70μmセルストレイナーでろ過し、遠心分離することによって細胞を回収した。   The washed tissue was enzymatically treated for 50 minutes using an enzyme solution in which 2 mg / ml collagenase was dissolved in DMEM medium. The resulting tissue was pipetted for 10 minutes using a 25 ml pipette. The 25 ml supernatant was centrifuged to recover the cells. The obtained cells were washed 5 times with a medium containing 15% serum in DMEM / F12 medium, filtered with a 70 μm cell strainer, and centrifuged to collect the cells.

回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、1回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、15%血清入りDMEM/F12培地にて5.0×106個/100μlの細胞懸濁液に調整し、96穴プレートでHAp/β-TCP多孔体130mg(日本特殊陶業製)に播種した後、37℃、5%CO2条件下で静置培養を4.5時間行なった。 The recovered cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C. under 5% CO 2 , and the first passaged cells were treated with trypsin-EDTA. After detaching from the cell culture flask, adjust the cell suspension to 5.0 × 10 6 cells / 100 μl with DMEM / F12 medium containing 15% serum, and 130 mg of HAp / β-TCP porous material (Japan) using a 96-well plate. After sowing on a special ceramic industry, static culture was performed for 4.5 hours under conditions of 37 ° C. and 5% CO 2 .

担体に細胞が接着後、6穴プレートへ移し、15%血清入りDMEM/F12培地にて13日間担体上で増殖させた。   After the cells adhered to the carrier, the cells were transferred to a 6-well plate and allowed to grow on the carrier for 13 days in a DMEM / F12 medium containing 15% serum.

移植動物としては、ヌードマウスKSNを用いた。ヌードマウス背部皮膚を切開し、細胞を播種した担体を皮下に入れ、皮膚を縫合した。   Nude mouse KSN was used as the transplanted animal. The dorsal skin of the nude mouse was incised, the carrier seeded with cells was placed subcutaneously, and the skin was sutured.

移植後6週にて試料を採取した。摘出した試料は、10%ホルマリン溶液にて固定し、常法に従ってパラフィンに包埋して連続組織切片を作成した。その後、切片にヘマトキシリン-エオジン染色(HE染色)を施し、組織学的に観察した。   Samples were collected 6 weeks after transplantation. The extracted sample was fixed with a 10% formalin solution and embedded in paraffin according to a conventional method to prepare a continuous tissue section. Thereafter, the sections were stained with hematoxylin-eosin (HE staining) and observed histologically.

移植後6週で摘出した移植体は生体に吸収されることなく原型を維持していた。また、HE染色した組織を観察した結果、硬組織は形成しているものの、幼弱で量も少なかった(図4)。   The graft removed 6 weeks after transplantation was maintained in its original form without being absorbed by the body. Moreover, as a result of observing the HE-stained tissue, a hard tissue was formed, but it was weak and the amount was small (FIG. 4).

実施例3:象牙芽細胞への分化誘導を促進する工程を含む移植実験
医師によるインフォームドコンセントの得られた患者(21歳男性)の智歯を使用した。治療のため抜歯した智歯をタービンで削り、歯髄を露出させ、無菌的に歯髄組織を採取し、10%抗生剤入りPBS溶液にて保存した。
Example 3: Transplantation experiment including a step of promoting differentiation induction into odontoblasts The wisdom of a patient (21-year-old male) who obtained informed consent by a doctor was used. The extracted wisdom tooth was scraped with a turbine to expose the pulp, and the pulp tissue was aseptically collected and stored in a PBS solution containing 10% antibiotic.

メスにて歯髄組織を約2mmの小片にし、PBS溶液にて5回洗浄した。   The pulp tissue was cut into small pieces of about 2 mm with a scalpel and washed 5 times with PBS solution.

2mg/mlコラゲナーゼをDMEM培地に溶解した酵素溶液を用いて、洗浄した組織を50分間酵素処理した。得られた組織を25ml用のピペットを用いて10分間ピペッティングした。25mlの上澄み液を遠心分離して細胞を回収した。得られた細胞をDMEM/F12培地に15%血清を入れた培地にて5回洗浄した後、70μmセルストレイナーでろ過し、遠心分離することによって細胞を回収した。   The washed tissue was enzymatically treated for 50 minutes using an enzyme solution in which 2 mg / ml collagenase was dissolved in DMEM medium. The resulting tissue was pipetted for 10 minutes using a 25 ml pipette. The 25 ml supernatant was centrifuged to recover the cells. The obtained cells were washed 5 times with a medium containing 15% serum in DMEM / F12 medium, filtered with a 70 μm cell strainer, and centrifuged to collect the cells.

回収した細胞を15%血清入りDMEM/F12培地に100μmol/lの濃度でアスコルビン酸を添加して37℃、5%CO2条件下で培養を行ない、1回継代した細胞をトリプシン-EDTAにて細胞培養用フラスコから剥離した後、15%血清入りDMEM/F12培地にて5.0×106個/100μlの細胞懸濁液に調整し、96穴プレートでHAp/β-TCP多孔体130mg(日本特殊陶業製)に播種した後、37℃、5%CO2条件下で静置培養を4.5時間行なった。 The recovered cells were cultured in DMEM / F12 medium containing 15% serum at a concentration of 100 μmol / l and cultured at 37 ° C under 5% CO 2 , and the passaged cells were trypsin-EDTA. After detaching from the cell culture flask, adjust the cell suspension to 5.0 × 10 6 cells / 100 μl with DMEM / F12 medium containing 15% serum, and 130 mg of HAp / β-TCP porous material (Japan) using a 96-well plate. After sowing on a special ceramic industry, static culture was performed for 4.5 hours under conditions of 37 ° C. and 5% CO 2 .

担体に細胞が接着後、6穴プレートへ移し、15%血清入りDMEM/F12培地にて7日間担体上で増殖させた。   After the cells adhered to the carrier, the cells were transferred to a 6-well plate and allowed to grow on the carrier for 7 days in a DMEM / F12 medium containing 15% serum.

更に分化誘導因子として100μmol/lアスコルビン酸、10-6mol/lの1,25(ジヒドロキシ)ビタミンD3、10mmol/lβ-Glycerophosphate、10-8mol/ l Dexamethasoneを15%血清入りDMEM/F12培地に添加した培地にて6日間培養し、象牙質再生用組成物を得た。 Furthermore, 100μmol / l ascorbic acid, 10 −6 mol / l 1,25 (dihydroxy) vitamin D 3 , 10 mmol / l β-Glycerophosphate, 10 −8 mol / l Dexamethasone as a differentiation inducer in DMEM / F12 medium with 15% serum Cultured for 6 days in a medium added to the above, a composition for dentin regeneration was obtained.

移植動物としては、ヌードマウスKSNを用いた。ヌードマウス背部皮膚を切開し、上記で得た象牙質再生用組成物を皮下に入れ、皮膚を縫合した。   Nude mouse KSN was used as the transplanted animal. Nude mouse dorsal skin was incised, and the dentin regeneration composition obtained above was placed subcutaneously and the skin was sutured.

移植後6週にて試料を採取した。摘出した試料は、10%ホルマリン溶液にて固定し、常法に従ってパラフィンに包埋して連続組織切片を作成した。その後、切片にHE染色を施し、組織学的に観察した。   Samples were collected 6 weeks after transplantation. The extracted sample was fixed with a 10% formalin solution and embedded in paraffin according to a conventional method to prepare a continuous tissue section. Thereafter, the sections were stained with HE and observed histologically.

移植後6週で摘出した移植体は生体に吸収されることなく原型を維持していた。また、HE染色した組織を観察した結果、比較例8と比較して顕著に象牙質様硬組織を形成していた(図5)。   The graft removed 6 weeks after transplantation was maintained in its original form without being absorbed by the body. Moreover, as a result of observing the HE-stained tissue, a dentin-like hard tissue was remarkably formed as compared with Comparative Example 8 (FIG. 5).

図1は、比較例1、比較例2および実施例1の条件下での細胞数とALPase活性およびその経時変化(7日目、10日目)を示す。FIG. 1 shows the number of cells, ALPase activity, and changes with time (7th day and 10th day) under the conditions of Comparative Example 1, Comparative Example 2 and Example 1. 図2は、比較例3、比較例4および比較例5の条件下での細胞数とALPase活性およびその経時変化(7日目、10日目)を示す。FIG. 2 shows the number of cells, ALPase activity, and changes with time (7th and 10th days) under the conditions of Comparative Example 3, Comparative Example 4 and Comparative Example 5. 図3は、比較例6、比較例7および実施例2の条件下での細胞数とALPase活性およびその経時変化(7日目、10日目)を示す。FIG. 3 shows the number of cells, ALPase activity, and changes with time (7th and 10th days) under the conditions of Comparative Example 6, Comparative Example 7 and Example 2. 図4は、培養ヒト歯髄細胞の移植により得られた組織のHE染色像を示す。FIG. 4 shows an HE-stained image of a tissue obtained by transplanting cultured human dental pulp cells. 図5は、培養ヒト歯髄細胞の移植により得られた組織のHE染色像(分化誘導(+))を示す。FIG. 5 shows an HE-stained image (differentiation induction (+)) of a tissue obtained by transplantation of cultured human dental pulp cells.

Claims (10)

分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することを含む、分化誘導された象牙芽細胞の製造方法。 Differentiation-induced, comprising culturing at least one type of isolated human dental pulp cells or cells that can differentiate into human dental pulp cells in the presence of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate A method for producing odontoblasts. 細胞を担体上で培養する、請求項1に記載の方法。 The method of claim 1, wherein the cells are cultured on a carrier. 1,25(ジヒドロキシ)ビタミンD3の培地中の濃度が1×10-8〜1×10-5mol/lであり、デキサメタゾンの培地中の濃度が1×10-9〜1×10-6mol/lであり、β−グリセロホスフェートの培地中の濃度が1〜30mmol/lである、請求項1又は2に記載の方法。 The concentration of 1,25 (dihydroxy) vitamin D 3 in the medium is 1 × 10 −8 to 1 × 10 −5 mol / l, and the concentration of dexamethasone in the medium is 1 × 10 −9 to 1 × 10 −6. The method according to claim 1, wherein the concentration is 1 mol / l and the concentration of β-glycerophosphate in the medium is 1 to 30 mmol / l. (i)分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を培養する工程、(ii)当該細胞を担体に播種して培養する工程、及び(iii)当該細胞を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートを含む培地中で培養する工程、を含む、請求項1から3の何れかに記載の方法。 (I) a step of culturing at least one of the separated human dental pulp cells or cells that can differentiate into human dental pulp cells, (ii) a step of seeding and culturing the cells on a carrier, and (iii) 1 of the cells. , 25 (dihydroxy) vitamin D 3 , culturing in a medium containing dexamethasone and β-glycerophosphate. 担体がセラミック系担体である、請求項4に記載の方法。 The method of claim 4, wherein the support is a ceramic-based support. 分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することを含む分化誘導された象牙芽細胞の製造方法により得られる、分化誘導された象牙芽細胞。 Differentiated ivory comprising culturing at least one of isolated human dental pulp cells or cells that can differentiate into human dental pulp cells in the presence of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate Differentiated odontoblasts obtained by the method for producing blasts. 請求項6に記載の分化誘導された象牙芽細胞を含む、象牙質再生用細胞組成物。 A cell composition for dentin regeneration comprising the differentiation-induced odontoblast according to claim 6. 請求項1から5の何れかに記載の方法により得られる分化誘導された象牙芽細胞を培養することを含む、象牙質の再生方法。 A method for regenerating dentin, comprising culturing differentiation-induced odontoblasts obtained by the method according to claim 1. 分離したヒト歯髄細胞又はヒト歯髄細胞に分化可能な細胞のうち少なくとも1種類を1,25(ジヒドロキシ)ビタミンD3、デキサメタゾン及びβ−グリセロホスフェートの存在下で培養することを含む分化誘導された象牙芽細胞の製造方法により得られる分化誘導された象牙芽細胞を培養することを含む象牙質の再生方法により再生された象牙質。 Differentiated ivory comprising culturing at least one of isolated human dental pulp cells or cells that can differentiate into human dental pulp cells in the presence of 1,25 (dihydroxy) vitamin D 3 , dexamethasone and β-glycerophosphate A dentin regenerated by a method for regenerating dentin, comprising culturing differentiation-induced odontoblasts obtained by the method for producing blasts. 請求項1から5の何れかに記載の方法により得られる分化誘導された象牙芽細胞、又は請求項5記載の方法により再生された象牙質を患者に移植することを含む、歯科患者の治療方法。


A method for treating a dental patient, comprising transplanting differentiation-induced odontoblasts obtained by the method according to any one of claims 1 to 5 or dentin regenerated by the method according to claim 5 to a patient. .


JP2005045417A 2004-05-07 2005-02-22 Method of inducing human pulp cell differentiation and composition for dentin regeneration Pending JP2005341961A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2005045417A JP2005341961A (en) 2004-05-07 2005-02-22 Method of inducing human pulp cell differentiation and composition for dentin regeneration
PCT/JP2005/008734 WO2005108558A1 (en) 2004-05-07 2005-05-06 Method of inducing human pulp cell differentiation and composition for dentin regeneration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004138467 2004-05-07
JP2005045417A JP2005341961A (en) 2004-05-07 2005-02-22 Method of inducing human pulp cell differentiation and composition for dentin regeneration

Publications (1)

Publication Number Publication Date
JP2005341961A true JP2005341961A (en) 2005-12-15

Family

ID=35320227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005045417A Pending JP2005341961A (en) 2004-05-07 2005-02-22 Method of inducing human pulp cell differentiation and composition for dentin regeneration

Country Status (2)

Country Link
JP (1) JP2005341961A (en)
WO (1) WO2005108558A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006211957A (en) * 2005-02-03 2006-08-17 Hitachi Medical Corp Method for regenerating dentin from human tooth pulp cell
WO2010073415A1 (en) * 2008-12-26 2010-07-01 株式会社 再生医療推進機構 Method for evaluating the culturability of living cells subjected to long-term freeze-storage, and storing and guaranteeing of same
JP2010213875A (en) * 2009-03-16 2010-09-30 Hiroshima Univ Crown restoration member
JP2011505970A (en) * 2007-12-14 2011-03-03 ノバ サウスイースタン ユニバーシティー Endodontic treatment and kit for delivering the same
WO2011062147A1 (en) 2009-11-17 2011-05-26 国立大学法人 岡山大学 Method for inducing differentiation of dental pulp cells into odontoblasts

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6010072855, Journal of the Stomatological society Japan(1989), Vol.56, No.4, p.540−561 *
JPN7010004228, Arch Oral Biol.(2003),Vol.48,No.10,p.717−722 *
JPN7010004229, Archives of Oral Biology (1993), Vol.38,No.9,p.769−777 *
JPN7010004230, Jpn. J. Oral Biol.(1998),Vol.40,No.5,p.549−556 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006211957A (en) * 2005-02-03 2006-08-17 Hitachi Medical Corp Method for regenerating dentin from human tooth pulp cell
JP2011505970A (en) * 2007-12-14 2011-03-03 ノバ サウスイースタン ユニバーシティー Endodontic treatment and kit for delivering the same
WO2010073415A1 (en) * 2008-12-26 2010-07-01 株式会社 再生医療推進機構 Method for evaluating the culturability of living cells subjected to long-term freeze-storage, and storing and guaranteeing of same
JP2010213875A (en) * 2009-03-16 2010-09-30 Hiroshima Univ Crown restoration member
WO2011062147A1 (en) 2009-11-17 2011-05-26 国立大学法人 岡山大学 Method for inducing differentiation of dental pulp cells into odontoblasts

Also Published As

Publication number Publication date
WO2005108558A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
AU2006253406B2 (en) Method of producing tooth and method of producing teeth and tissue
RU2462256C2 (en) Method for making tooth and tooth made by such method
JP5069572B2 (en) Method for producing mesenchymal cells, method for producing teeth, and mesenchymal cells for tooth formation
JP4884678B2 (en) Dentin regeneration from human dental pulp cells
JP4991203B2 (en) Teeth manufacturing method
US8822212B2 (en) Methods for forming tooth root and periodontal tissue unit, and regenerated tooth
JP2005341961A (en) Method of inducing human pulp cell differentiation and composition for dentin regeneration
CN102131489A (en) Method for restoring missing tooth and method for producing restorative material
JP4991204B2 (en) Teeth manufacturing method
KR101503939B1 (en) Method for preparation of cartilage cell
JP2003052365A (en) Separation of mesenchymal stem cell from mammalian animal and method for using the same
EP1550470A1 (en) Method of regenerating tooth germ and regenerated tooth germ
WO2005014070A1 (en) Method of bone regeneration
KR20110123248A (en) Method for producing tooth
JP4781037B2 (en) Identification and selection of human dental pulp cells
JP2004357567A (en) Method for regenerating tooth germ
JP2005270647A (en) Regeneration method of dentine, and implant entity used for this
JP2007037635A (en) Gelled composition for periodontium regeneration
Hosein Strategies for whole tooth regeneration and possible rejuvenation of adult dental pulp stem cells.
Liu et al. Biological tooth root reconstruction with a scaffold of swine treated dentin matrix
JP2005145926A (en) Tooth regeneration method
JP2020036550A (en) Production method of periodontal ligament or ligament cell
JPWO2003101502A1 (en) Tooth germ regeneration method and regeneration tooth germ

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20071129

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080118

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101221

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110705